Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CoRISMA is a medical device company developing a novel mechanical circulatory support (MCS) system designed to treat patients with heart failure. The company's flagship technology is a wireless, fully implantable heart pump that aims to eliminate the need for external power cables, which are a primary source of infection in traditional ventricular assist devices. By utilizing a transcutaneous energy transfer system, CoRISMA's device provides a less invasive and more patient-friendly alternative for long-term cardiac support. The system is designed to be implanted via a minimally invasive procedure, potentially expanding the pool of patients eligible for mechanical heart support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CoRISMA MCS Systems.